JPRN-UMIN000041702
Completed
未知
Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Pre-viously Untreated Extensive-Stage Small-Cell Lung Cancer: A Systematic Review and Network Me-ta-analysis - Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Pre-viously Untreated Extensive-Stage Small-Cell Lung Cancer
ConditionsExtensive stage small cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Extensive stage small cell lung cancer
- Sponsor
- Showa University
- Enrollment
- 3879
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •non\-small cell lung cancer patients Poor performance status (3 or more) Patients previously treated with systemic anticancer therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Comparison of two routes of injection of MMR vaccine in the treatment of multiple wartsHealth Condition 1: null- multiple verruca vulgarisCTRI/2018/02/012128Indian association of Dermatologists Venereologists and leprologists West Bengal
Not yet recruiting
Not Applicable
Investigate the safety and efficacy of small cell lung cancer,Kidney cancer and Primary liver cancer immunotherapyHistopathologically confirmed small cell lung cancer (SCLC)Histopathologically confirmed Kidney cancerHistopathologically confirmed Liver cancerACTRN12618001337268The First Teaching Hospital, Inner Mongolia Medical University50
Completed
Phase 2
A clinical trial to study the effect of two drugs- Mycobacterium w vaccine and imiquimod in patients with genital wartsHealth Condition 1: null- Patients with anogenital wartsCTRI/2009/091/000055Department of Biotechnology Govt of India110
Recruiting
Not Applicable
Safety and efficacy of combination immunotherapy with nivolumab and ipilimumab for elderly lung cancer patients: a cohort studyJPRN-UMIN000046353ational Hospital Organization Kyoto Medical Center60
Completed
Phase 1
Assessment of efficacy and safety of immunotherapy for unresectable locally advanced pancreatic cancer.pancreatic ductal carcinomaJPRN-UMIN000000769agoya University Hospital15